Let’s talk about sex
Could in silico medicine make healthcare equally precise for all?
News
109 items-
Discover more
-
Exclusive Member Briefing Sessions on In Silico Methods in Emerging European Health Policy and Regulation
On 21 and 27 of January 2026, the VPH Society is organising two exclusive online briefing sessions to present the latest updates in the policy and regulatory context and how this is effecting the in silico medicine field.
Discover more -
Interview with science-to-policy expert François Busquet from Altertox
In 2025, VPH collaborated with Altertox with the aim of engaging with policy makers in the European Parliament on the topic of in silico medicine. In this interview, we share insights on how to translate scientific advances into policy-relevant outputs.
Discover more -
VPH invited to pitch at EMA/HMA Annual data forum
On 9 December 2025, VPH was invited to present high level pitch at the EMA Annual Data forum, on the how digital twins could shape the future trends in evidence generation.
Discover more
-
Belgian MEP Liesbet SOMMEN visits VPH Team
On 12 December 2025, the VPH Society hosted MEP Liesbet Sommen at University Hospital Gasthuisberg, Leuven. The meeting served as a strategic dialogue on the role of Virtual Human Twins (VHTs) and AI in securing Europe’s leadership in medical technology.
Discover more
-
In the literature: December 2025 highlights
Discover the recently published papers from our community!
Discover more -
VPH at the dealiiX Digital Twins Research School
VPH participated in the Research School on Digital Twins of the Human Body in Trieste, supporting the dissemination of advanced modelling, simulation, and high-performance computing approaches that underpin next-generation digital twins in healthcare.
Discover more
-
VPH at high-level meeting on Rare Diseases 2025
Our director, Prof. Liesbet Geris attended the event and contributed to the session on “Resilience and Reliability: Securing Rare Disease Diagnosis and Care in a Changing World" bringing the in silico medicine perspective to the discussion.
Discover more -
A Watershed Moment for In Silico Medicine in the EU MDR Revision
The proposed MDR revision marks a turning point for our community, explicitly recognising in silico modelling & simulation as a source of evidence in EU medical device guidance.
Discover more -
EIC Pathfinder Challenge on Biotechnology for Healthy Ageing launched
In November 2025, the European Innovation Council (EIC) launched a new Pathfinder Challenge on Biotechnology for Healthy Ageing under the EIC Work Programme 2026.
Discover more -
Horizon Europe 2026-2027 Work Programme published
The European Commission has published the Horizon Europe Work Programme for 2026 and 2027, setting out the next wave of research and innovation funding under the EU’s flagship programme. The overall programme allocates €14 billion to strategic research and innovation priorities across multiple clusters, including health, digital, industry, climate and more.
Discover more -
Commission welcomes agreement on major reform of EU pharmaceutical rules
The European Commission has welcomed a political agreement reached by the European Parliament and the Council to modernise the EU pharmaceutical legislation — the most significant overhaul in over 20 years.
Discover more
